C/EBPβ/AEP pathway dictates both Alzheimer's disease and longevity: Study

C/EBPβ/AEP pathway dictates both Alzheimer's disease and longevity: Study
Neuronal C/EBPβ escalation shortens the life span of mice, leading to neural excitation. Credit: SIAT

Cognitive decline during normal aging is exacerbated in neurodegenerative disease including Alzheimer's disease (AD). While it is not yet known exactly what causes AD, there are a number of risk factors that make a person more likely to get it. Among them, aging is the most prominent one.

Recently, a research team led by Prof. Keqiang Ye from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences has revealed that C/EBPβ/Asparagine endopeptidase (AEP), a -activated transcription factor and its downstream player in the brain, accelerates the progression of AD. Moreover, this pathway in nerve cells in the brain dictates as well.

The study was published in Science Advances on March 30.

To explore C/EBPβ's role in aged nerve cells, Prof. Ye's lab generated a that selectively overexpresses C/EBPβ in the brain to mimic aged animals. They found that the mice's life span was shortened in a gene dose-dependent manner.

Usually, normal life expectancy for a mouse is around 24–28 months. However, the life span for a mouse carrying one copy of overexpressed C/EBPβ is around 12–18 months and 5–9 months for mice carrying two copies. By contrast, deleting one copy of the C/EBPβ gene increases the life span with the most long-lived mice living more than 30 months.

C/EBPβ/AEP pathway dictates both Alzheimer's disease and longevity: Study
C/EBPβ mediates insulin/FOXO1 signaling in nerve cells in human brains and is inversely correlated with life span. Credit: SIAT

Remarkably, the mice with C/EBPβ overexpression in nerve cells exhibited impaired cognitive function, similar to dementia in the aged brain. On the other hand, these animals also displayed prominent neuro-excitation.

"The C/EBPβ gene is elevated in human brains during aging. It peaks in individuals 60 to 84 years old and declines in those more than 85 years old," said Prof. Ye. Long-lived individuals usually show less expression of AEP genes in nerve cells, whereas short-lived individuals show greater AEP gene expression.

In worms, neural excitation increases with age and inhibition of excitation increases longevity. The scientists found that high levels of C/EBPβ or AEP in shorten the worm's life span, whereas such gene expression in muscles has no effect on longevity. Similar to mice, deletion of these genes in worms increases the life span. Remarkably, inhibition of AEP using a drug increases the life expectancy of worms.

Life span regulation by insulin-like metabolic control is analogous to mammalian longevity enhancement induced by , suggesting a general link between metabolism and longevity. The researchers found that C/EBPβ/AEP signaling was inversely correlated with insulin signaling in the . With the lowest insulin signaling in humans in their seventies and eighties, C/EBPβ/AEP activity peaks. However, in humans with extended longevity, C/EBPβ/AEP activity declines, while insulin signaling climbs in the brain.

Loss of γ-Aminobutanoic acid (GABA), the primary inhibitory neurotransmitter in the brain, is a key component of AD. Loss of GABA and GABAergic neurons in AD patients may be responsible for network hyperactivity manifesting as seizures, resembling what is observed in C/EBPβ transgenic mice. Prof. Ye found that extended longevity and cognitive preservation in humans is associated with coordinate downregulation of both C/EBPβ and AEP.

"This finding expands this pathway's function beyond the control of AD pathologies to the regulation of ," said Prof. Ye.

More information: Yiyuan Xia et al, Neuronal C/EBPβ/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression, Science Advances (2022). DOI: 10.1126/sciadv.abj8658

Journal information: Science Advances

Citation: C/EBPβ/AEP pathway dictates both Alzheimer's disease and longevity: Study (2022, March 31) retrieved 27 January 2023 from https://medicalxpress.com/news/2022-03-cebpaep-pathway-dictates-alzheimer-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Women are more susceptible to Alzheimer's: New evidence


Feedback to editors